Robotic Radiotherapy Market Size by Product (System, Software, 3D Camera), Technology (LINAC, Stereotactic, Particle Therapy), Application (Lung, Breast, Colorectal), End-User (Hospitals, Radiotherapy Centres), & Region - Global Forecast to 2028
The global robotic radiotherapy market is projected to reach USD 1.9 billion by 2028 from USD 1.1 billion in 2023, growing at a CAGR of 11.9% during the forecast period. The rising prevalence of cancer and the growing use of robotic radiotherapy is one of the major factors anticipated to boost market growth in the forecasting years.
“3D cameras (SGRT) segment of global robotic radiotherapy market to grow with the highest CAGR in the forecast period.”
On the basis of product, the robotic radiotherapy market is segmented into radiotherapy systems, software, 3D cameras, and others. The 3D cameras segment is expected to register the highest CAGR in the forecast period. Growth in this segment is majorly driven by the ability to offer non-invasive, real-time, 6-degree dimensional patient positioning and monitoring before and during the radiation therapy treatment process, resulting in accurate treatment delivery and wide acceptance by cancer facilities. However, factors such as significant maintenance costs associated with SGRT products, as well as the slow implementation of regulatory guidelines for robotic radiotherapy across emerging countries, are expected to restrain market growth.
“Lung cancer segment, by application, accounted for the largest market share of global robotic radiotherapy market in 2020.”
Based on application, the global robotic radiotherapy market is segmented into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer, and other cancers. The lung cancer segment accounted for the largest share of the global robotic radiotherapy market in 2022. The major drivers of this segment are increasing smoking rates, exposure to air pollutants, especially in urban areas with poor air quality, and exposure to carcinogens in mining, construction, and manufacturing. Modern lifestyles and dietary habits may further elevate the risk of lung cancer. As the global population ages, lung cancer incidence tends to rise, potentially leading to a higher number of cases.
“Increased installations and government initiatives to drive the segment growth of hospitals end-user segment.”
Based on the end user, the robotic radiotherapy market is segmented into hospitals and independent radiotherapy centers. Hospitals are the major end users of robotic radiotherapy products. The large share of this end-user segment is primarily attributed to the demand for automated radiation therapy systems, advancement in automated radiation therapy systems and the increasing installations of ART stations, and the rising government investments for effective ART and treatment.
“The APAC market, by region, to register highest growth rate in the forecast period.”
On the basis of region, the robotic radiotherapy market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia-Pacific market is likely witness significant growth owing to increase in disposable income and increase in cancer patient pool. Focus on governments on investment on robotic radiotherapy systems, modernization of industrial and public infrastructures, and rising penetration of cutting-edge radiation therapy in hospitals. However, a dearth of skilled professionals for the operation of advanced instruments, slow implementation of therapy due to budgetary constraints, and pricing pressures faced by prominent product manufacturers are the key factors restraining the growth of the robotic radiotherapy market despite the great opportunities available in the APAC region.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
This report studies the robotic radiotherapy market based on product, technology, application, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.
This report provides insights on the following pointers:
“3D cameras (SGRT) segment of global robotic radiotherapy market to grow with the highest CAGR in the forecast period.”
On the basis of product, the robotic radiotherapy market is segmented into radiotherapy systems, software, 3D cameras, and others. The 3D cameras segment is expected to register the highest CAGR in the forecast period. Growth in this segment is majorly driven by the ability to offer non-invasive, real-time, 6-degree dimensional patient positioning and monitoring before and during the radiation therapy treatment process, resulting in accurate treatment delivery and wide acceptance by cancer facilities. However, factors such as significant maintenance costs associated with SGRT products, as well as the slow implementation of regulatory guidelines for robotic radiotherapy across emerging countries, are expected to restrain market growth.
“Lung cancer segment, by application, accounted for the largest market share of global robotic radiotherapy market in 2020.”
Based on application, the global robotic radiotherapy market is segmented into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer, and other cancers. The lung cancer segment accounted for the largest share of the global robotic radiotherapy market in 2022. The major drivers of this segment are increasing smoking rates, exposure to air pollutants, especially in urban areas with poor air quality, and exposure to carcinogens in mining, construction, and manufacturing. Modern lifestyles and dietary habits may further elevate the risk of lung cancer. As the global population ages, lung cancer incidence tends to rise, potentially leading to a higher number of cases.
“Increased installations and government initiatives to drive the segment growth of hospitals end-user segment.”
Based on the end user, the robotic radiotherapy market is segmented into hospitals and independent radiotherapy centers. Hospitals are the major end users of robotic radiotherapy products. The large share of this end-user segment is primarily attributed to the demand for automated radiation therapy systems, advancement in automated radiation therapy systems and the increasing installations of ART stations, and the rising government investments for effective ART and treatment.
“The APAC market, by region, to register highest growth rate in the forecast period.”
On the basis of region, the robotic radiotherapy market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia-Pacific market is likely witness significant growth owing to increase in disposable income and increase in cancer patient pool. Focus on governments on investment on robotic radiotherapy systems, modernization of industrial and public infrastructures, and rising penetration of cutting-edge radiation therapy in hospitals. However, a dearth of skilled professionals for the operation of advanced instruments, slow implementation of therapy due to budgetary constraints, and pricing pressures faced by prominent product manufacturers are the key factors restraining the growth of the robotic radiotherapy market despite the great opportunities available in the APAC region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
- By Designation: C-level–10%, Director-level–14%, and Others–76%
- By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, MEA- 3%
Research Coverage
This report studies the robotic radiotherapy market based on product, technology, application, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (growing demand for non-invasive treatments, technological advancements, rising prevalence of cancer, growing use of automated radiation therapy for cancer treatment), restraints (lack of adequate healthcare, high cost of automated radiation therapy systems, complex nature of technology, dearth of skilled radiologist), opportunities (rising healthcare expenditure across developing countries, growing government and private investments, adoption of radiation therapy), and challenges (risk of radiation exposure, competition from alternative treatment modalities) influencing the growth of robotic radiotherapy market
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the robotic radiotherapy market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the robotic radiotherapy market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIES COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 LIMITATIONS
1.5 MARKET STAKEHOLDERS
1.5.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.2 PRIMARY RESEARCH
2.2.2.1 Primary sources
2.2.2.2 Key data from secondary sources
2.2.2.3 Breakdown of primaries
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
FIGURE 4 MARKET SIZE ESTIMATION FOR ROBOTIC RADIOTHERAPY: APPROACH 1 (COMPANY REVENUE ESTIMATION)
2.3.1.2 Approach 2: Customer-based market estimation
FIGURE 5 ROBOTIC RADIOTHERAPY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.3.1.3 Approach 3: Top-down approach
2.3.1.4 Approach 4: Primary interviews
2.3.2 TOP-DOWN APPROACH
2.4 DATA VALIDATION APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ASSESSMENT
2.6 STUDY ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 1 LIMITATIONS AND ASSOCIATED RISKS
2.8 GROWTH RATE ASSUMPTIONS
2.9 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 7 ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 8 ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 9 ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 10 ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT: ROBOTIC RADIOTHERAPY MARKET
4 PREMIUM INSIGHTS
4.1 ROBOTIC RADIOTHERAPY MARKET OVERVIEW
FIGURE 12 INCREASING GERIATRIC POPULATION AND GROWING R&D INVESTMENTS TO DRIVE MARKET
4.2 ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 13 RADIOTHERAPY SYSTEMS TO DOMINATE MARKET IN 2028
4.3 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY AND END USER, 2022 (USD MILLION)
FIGURE 14 HOSPITALS DOMINATED END-USER MARKET IN 2022
4.4 ROBOTIC RADIOTHERAPY MARKET: COMPARISON OF COUNTRY-WISE GROWTH RATES
FIGURE 15 INDIA AND CHINA TO SHOW HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 ROBOTIC RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of cancer
TABLE 2 PROJECTED INCREASE IN CANCER CASES, 2020–2040
5.2.1.2 Growing demand for noninvasive treatment
5.2.2 RESTRAINTS
5.2.2.1 Premium Product Pricing
5.2.2.2 Complexities associated with automated/robotic radiotherapy
5.2.3 OPPORTUNITIES
5.2.3.1 Rising healthcare expenditure across emerging economies
5.2.3.2 Government and private investments to boost cancer treatment availability
5.2.4 CHALLENGES
5.2.4.1 Risk of radiation exposure
5.2.4.2 Dearth of skilled personnel
5.3 TECHNOLOGY ANALYSIS
5.4 PORTER’S FIVE FORCES ANALYSIS
TABLE 3 ROBOTIC RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 KEY STAKEHOLDERS AND BUYING CRITERIA
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS
TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
5.6 REGULATORY ANALYSIS
5.6.1 US
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.6.2 EUROPE
5.6.3 JAPAN
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.7 REIMBURSEMENT SCENARIO
TABLE 7 CPT CODES FOR IMRT
TABLE 8 CPT CODES FOR SBRT
TABLE 9 CPT CODES FOR PROTON BEAM THERAPY
TABLE 10 FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022
TABLE 11 PROPOSED AMBULATORY PAYMENT CLASSIFICATION 2023 RATES
TABLE 12 IMPACT OF CLINICAL LABOR PRICE CHANGES ON RADIATION ONCOLOGY SERVICES
5.8 ECOSYSTEM ANALYSIS
5.9 VALUE CHAIN ANALYSIS
5.9.1 RESEARCH & DEVELOPMENT
5.9.2 PROCUREMENT AND PRODUCT DEVELOPMENT
5.9.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES
FIGURE 18 VALUE CHAIN ANALYSIS IN ROBOTIC RADIOTHERAPY MARKET
5.10 SUPPLY CHAIN ANALYSIS
5.10.1 PROMINENT COMPANIES
5.10.2 SMALL & MEDIUM-SIZED COMPANIES
5.10.3 END USERS
FIGURE 19 SUPPLY CHAIN ANALYSIS OF ROBOTIC RADIOTHERAPY MARKET
5.11 PRICING ANALYSIS
TABLE 13 PRICING ANALYSIS OF RADIOTHERAPY SYSTEMS (USD)
5.12 PATENT ANALYSIS
FIGURE 20 TOP TEN PATENT APPLICANTS FOR RADIOTHERAPY (JANUARY 2012 TO JUNE 2022)
FIGURE 21 TOP TEN PATENT INVENTORS FOR RADIOTHERAPY (JANUARY 2012 TO JUNE 2023)
FIGURE 22 TOP TEN PATENT OWNERS FOR RADIOTHERAPY (JANUARY 2012 TO JUNE 2023)
5.13 TRADE ANALYSIS
TABLE 14 IMPORT DATA FOR RADIOTHERAPY SYSTEMS (HS CODE 9022), BY COUNTRY, 2018–2022 (USD THOUSAND)
TABLE 15 EXPORT DATA FOR RADIOTHERAPY SYSTEMS (HS CODE 9022), BY COUNTRY, 2018–2022 (USD THOUSAND)
5.14 KEY CONFERENCES AND EVENTS IN 2022–2023
TABLE 16 ROBOTIC RADIOTHERAPY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2022–2023
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 23 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
6 ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 17 ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
6.2 RADIOTHERAPY SYSTEMS
6.2.1 RISING USE OF AI AND AUTOMATION TO DRIVE MARKET
TABLE 18 RADIOTHERAPY SYSTEMS MARKET, BY REGION, 2020–2028 (USD MILLION)
6.3 SOFTWARE
6.3.1 NEED TO ENSURE TREATMENT EFFECTIVENESS AND ACCURACY TO BOOST GROWTH
TABLE 19 SOFTWARE MARKET, BY REGION, 2020–2028 (USD MILLION)
6.4 3D CAMERAS
6.4.1 GROWING USE OF SGRT TO DRIVE DEMAND
TABLE 20 3D CAMERAS MARKET, BY REGION, 2020–2028 (USD MILLION)
6.5 OTHER PRODUCTS
TABLE 21 OTHER ROBOTIC RADIOTHERAPY MARKET, BY REGION, 2020–2028 (USD MILLION)
7 ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 22 ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)
7.2 LINEAR ACCELERATORS
TABLE 23 LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2028 (USD MILLION)
7.2.1 CONVENTIONAL LINEAR ACCELERATORS
7.2.1.1 Longer treatment duration to limit adoption
7.2.2 MRI LINEAR ACCELERATORS
7.2.2.1 Rising awareness about benefits to enhance demand
7.3 STEREOTACTIC RADIATION THERAPY
TABLE 24 STEREOTACTIC RADIATION THERAPY MARKET, BY TYPE, 2020–2028 (USD MILLION)
7.3.1 CYBERKNIFE
7.3.1.1 Precision and correction capabilities to boost adoption
7.3.2 GAMMA KNIFE
7.3.2.1 Ongoing product development to drive market
7.4 PARTICLE THERAPY SYSTEMS
TABLE 25 PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION)
7.4.1 PROTON BEAM THERAPY
7.4.1.1 Rising establishment of proton therapy cancer centers to drive market
7.4.2 HEAVY ION THERAPY
7.4.2.1 Limited number of facilities to slow growth
8 ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 26 ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
8.2 LUNG CANCER
8.2.1 LUNG CANCER TO DOMINATE APPLICATIONS MARKET
TABLE 27 ROBOTIC RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2020–2028 (USD MILLION)
8.3 BREAST CANCER
8.3.1 INCREASING INCIDENCE OF BREAST CANCER TO DRIVE MARKET
TABLE 28 ROBOTIC RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2020–2028 (USD MILLION)
8.4 PROSTATE CANCER
8.4.1 PREFERENCE FOR NONINVASIVE TREATMENT TO BOOST GROWTH
TABLE 29 ROBOTIC RADIOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2020–2028 (USD MILLION)
8.5 HEAD & NECK CANCER
8.5.1 GROWING UTILIZATION OF CYBERKNIFE FOR TREATMENT TO DRIVE MARKET
TABLE 30 ROBOTIC RADIOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2020–2028 (USD MILLION)
8.6 COLORECTAL CANCER
8.6.1 RISING INCIDENCE OF COLORECTAL CANCER TO SUPPORT GROWTH
TABLE 31 ROBOTIC RADIOTHERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2020–2028 (USD MILLION)
8.7 OTHER CANCERS
TABLE 32 ROBOTIC RADIOTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2020–2028 (USD MILLION)
9 ROBOTIC RADIOTHERAPY MARKET, BY END USER
9.1 INTRODUCTION
TABLE 33 ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)
9.2 HOSPITALS
9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO PROPEL MARKET
TABLE 34 ROBOTIC RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2020–2028 (USD MILLION)
9.3 INDEPENDENT RADIOTHERAPY CENTERS
9.3.1 LIMITED SURGICAL CAPABILITIES OF AVAILABLE PRODUCTS TO RESTRAIN ADOPTION
TABLE 35 ROBOTIC RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2020–2028 (USD MILLION)
10 ROBOTIC RADIOTHERAPY MARKET, BY REGION
10.1 INTRODUCTION
TABLE 36 ROBOTIC RADIOTHERAPY MARKET, BY REGION, 2020–2028 (USD MILLION)
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 24 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET SNAPSHOT
TABLE 37 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY, 2020–2028 (USD MILLION)
TABLE 38 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)
TABLE 40 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
TABLE 41 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)
10.2.2 US
10.2.2.1 US to dominate North American market over forecast period
TABLE 42 US: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Increasing government initiatives and favorable reimbursement to drive market
TABLE 43 CANADA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
TABLE 44 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY, 2020–2028 (USD MILLION)
TABLE 45 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
TABLE 46 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)
TABLE 47 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
TABLE 48 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 Increasing aging population and rising life expectancy to drive market
TABLE 49 GERMANY: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Well-developed healthcare sector and rising geriatric population to drive market
TABLE 50 FRANCE: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.3.4 UK
10.3.4.1 High burden of chronic diseases to support adoption
TABLE 51 UK: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Increasing geriatric population to drive market
TABLE 52 ITALY: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Technological developments in healthcare to drive market
TABLE 53 SPAIN: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 54 REST OF EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 25 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET SNAPSHOT
TABLE 55 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY, 2020–2028 (USD MILLION)
TABLE 56 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
TABLE 57 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)
TABLE 58 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
TABLE 59 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising geriatric population and surgical procedures to drive market
TABLE 60 JAPAN: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.3 CHINA
10.4.3.1 Developing healthcare infrastructure to drive market
TABLE 61 CHINA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Rising awareness and government support to boost growth
TABLE 62 INDIA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Well-established healthcare system to favor adoption
TABLE 63 AUSTRALIA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.6 SOUTH KOREA
10.4.6.1 Growing target patient population to drive market
TABLE 64 SOUTH KOREA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC
TABLE 65 REST OF ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.5 REST OF THE WORLD
10.5.1 REST OF THE WORLD: RECESSION IMPACT
TABLE 66 REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
TABLE 67 REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)
TABLE 68 REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
TABLE 69 REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES
FIGURE 26 KEY DEVELOPMENTS IN ROBOTIC RADIOTHERAPY MARKET (2019 TO 2023)
11.3 REVENUE ANALYSIS
FIGURE 27 REVENUE ANALYSIS OF TOP FIVE PLAYERS (2019–2022)
11.4 MARKET SHARE ANALYSIS: ROBOTIC RADIOTHERAPY MARKET, BY KEY PLAYER (2022)
FIGURE 28 ROBOTIC RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 70 ROBOTIC RADIOTHERAPY MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX (2022)
11.5.1 STARS
11.5.2 PERVASIVE PLAYERS
11.5.3 EMERGING LEADERS
11.5.4 PARTICIPANTS
FIGURE 29 ROBOTIC RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX, 2022
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 DYNAMIC COMPANIES
11.6.3 RESPONSIVE COMPANIES
11.6.4 STARTING BLOCKS
FIGURE 30 COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
11.7 COMPETITIVE BENCHMARKING
11.7.1 OVERALL COMPANY FOOTPRINT
TABLE 71 OVERALL FOOTPRINT ANALYSIS: ROBOTIC RADIOTHERAPY MARKET
11.7.2 COMPANY PRODUCT FOOTPRINT
TABLE 72 PRODUCT FOOTPRINT ANALYSIS: ROBOTIC RADIOTHERAPY MARKET
11.7.3 COMPANY REGIONAL FOOTPRINT
TABLE 73 REGIONAL FOOTPRINT ANALYSIS: ROBOTIC RADIOTHERAPY MARKET
11.8 COMPETITIVE SCENARIO (2019–2023)
11.8.1 PRODUCT LAUNCHES & APPROVALS
11.8.2 DEALS
11.8.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, Recent Developments, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats)*
12.1.1 SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.)
TABLE 74 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
FIGURE 31 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2022)
12.1.2 ELEKTA
TABLE 75 ELEKTA: COMPANY OVERVIEW
FIGURE 32 ELEKTA: COMPANY SNAPSHOT (2022)
12.1.3 ACCURAY INCORPORATED
TABLE 76 ACCURAY INCORPORATED: COMPANY OVERVIEW
FIGURE 33 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2022)
12.1.4 VIEWRAY TECHNOLOGIES, INC.
TABLE 77 VIEWRAY TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 34 VIEWRAY TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
12.1.5 C-RAD
TABLE 78 C-RAD: COMPANY OVERVIEW
FIGURE 35 C-RAD: COMPANY SNAPSHOT (2022)
12.1.6 IBA
TABLE 79 IBA: COMPANY OVERVIEW
FIGURE 36 IBA: COMPANY SNAPSHOT (2022)
12.1.7 HITACHI LTD.
TABLE 80 HITACHI LTD.: COMPANY OVERVIEW
FIGURE 37 HITACHI LTD.: COMPANY SNAPSHOT (2021)
12.1.8 MEVION MEDICAL SYSTEMS
TABLE 81 MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW
12.1.9 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
TABLE 82 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: COMPANY OVERVIEW
12.1.10 P-CURE
TABLE 83 P-CURE: COMPANY OVERVIEW
12.1.11 PROVISION HEALTHCARE
TABLE 84 PROVISION HEALTHCARE: COMPANY OVERVIEW
12.1.12 SUMITOMO HEAVY INDUSTRY LTD.
TABLE 85 SUMITOMO HEAVY INDUSTRY LTD.: COMPANY OVERVIEW
FIGURE 38 SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT (2021)
12.1.13 PHILIPS HEALTHCARE
TABLE 86 PHILIPS HEALTHCARE: COMPANY OVERVIEW
FIGURE 39 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022)
12.1.14 RAYSEARCH LABORATORIES
TABLE 87 RAYSEARCH LABORATORIES: COMPANY OVERVIEW
FIGURE 40 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2022)
12.1.15 PROTOM INTERNATIONAL, INC.
TABLE 88 PROTOM INTERNATIONAL, INC.: COMPANY OVERVIEW
12.1.16 OPTIVUS PROTON THERAPY, INC.
TABLE 89 OPTIVUS PROTON THERAPY, INC.: COMPANY OVERVIEW
12.1.17 TOSHIBA CORPORATION
TABLE 90 TOSHIBA CORPORATION: COMPANY OVERVIEW
FIGURE 41 TOSHIBA CORPORATION: COMPANY SNAPSHOT (2022)
12.1.18 VISION RT LTD.
TABLE 91 VISION RT LTD.: COMPANY OVERVIEW
12.1.19 ADVANCED ONCOTHERAPY PLC
TABLE 92 ADVANCED ONCOTHERAPY PLC: COMPANY OVERVIEW
12.1.20 MIM SOFTWARE INC.
TABLE 93 MIM SOFTWARE INC.: COMPANY OVERVIEW
*Business Overview, Products/Services/Solutions Offered, Recent Developments, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 STANDARD IMAGING, INC.
12.2.2 BRAINLAB AG
12.2.3 MAGNETTX ONCOLOGY SOLUTIONS LTD.
12.2.4 PTW FREIBURG GMBH
12.2.5 DOSISOFT SA
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIES COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 LIMITATIONS
1.5 MARKET STAKEHOLDERS
1.5.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.2 PRIMARY RESEARCH
2.2.2.1 Primary sources
2.2.2.2 Key data from secondary sources
2.2.2.3 Breakdown of primaries
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
FIGURE 4 MARKET SIZE ESTIMATION FOR ROBOTIC RADIOTHERAPY: APPROACH 1 (COMPANY REVENUE ESTIMATION)
2.3.1.2 Approach 2: Customer-based market estimation
FIGURE 5 ROBOTIC RADIOTHERAPY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.3.1.3 Approach 3: Top-down approach
2.3.1.4 Approach 4: Primary interviews
2.3.2 TOP-DOWN APPROACH
2.4 DATA VALIDATION APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ASSESSMENT
2.6 STUDY ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 1 LIMITATIONS AND ASSOCIATED RISKS
2.8 GROWTH RATE ASSUMPTIONS
2.9 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 7 ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 8 ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 9 ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 10 ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT: ROBOTIC RADIOTHERAPY MARKET
4 PREMIUM INSIGHTS
4.1 ROBOTIC RADIOTHERAPY MARKET OVERVIEW
FIGURE 12 INCREASING GERIATRIC POPULATION AND GROWING R&D INVESTMENTS TO DRIVE MARKET
4.2 ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 13 RADIOTHERAPY SYSTEMS TO DOMINATE MARKET IN 2028
4.3 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY AND END USER, 2022 (USD MILLION)
FIGURE 14 HOSPITALS DOMINATED END-USER MARKET IN 2022
4.4 ROBOTIC RADIOTHERAPY MARKET: COMPARISON OF COUNTRY-WISE GROWTH RATES
FIGURE 15 INDIA AND CHINA TO SHOW HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 ROBOTIC RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of cancer
TABLE 2 PROJECTED INCREASE IN CANCER CASES, 2020–2040
5.2.1.2 Growing demand for noninvasive treatment
5.2.2 RESTRAINTS
5.2.2.1 Premium Product Pricing
5.2.2.2 Complexities associated with automated/robotic radiotherapy
5.2.3 OPPORTUNITIES
5.2.3.1 Rising healthcare expenditure across emerging economies
5.2.3.2 Government and private investments to boost cancer treatment availability
5.2.4 CHALLENGES
5.2.4.1 Risk of radiation exposure
5.2.4.2 Dearth of skilled personnel
5.3 TECHNOLOGY ANALYSIS
5.4 PORTER’S FIVE FORCES ANALYSIS
TABLE 3 ROBOTIC RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 KEY STAKEHOLDERS AND BUYING CRITERIA
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS
TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
5.6 REGULATORY ANALYSIS
5.6.1 US
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.6.2 EUROPE
5.6.3 JAPAN
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.7 REIMBURSEMENT SCENARIO
TABLE 7 CPT CODES FOR IMRT
TABLE 8 CPT CODES FOR SBRT
TABLE 9 CPT CODES FOR PROTON BEAM THERAPY
TABLE 10 FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022
TABLE 11 PROPOSED AMBULATORY PAYMENT CLASSIFICATION 2023 RATES
TABLE 12 IMPACT OF CLINICAL LABOR PRICE CHANGES ON RADIATION ONCOLOGY SERVICES
5.8 ECOSYSTEM ANALYSIS
5.9 VALUE CHAIN ANALYSIS
5.9.1 RESEARCH & DEVELOPMENT
5.9.2 PROCUREMENT AND PRODUCT DEVELOPMENT
5.9.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES
FIGURE 18 VALUE CHAIN ANALYSIS IN ROBOTIC RADIOTHERAPY MARKET
5.10 SUPPLY CHAIN ANALYSIS
5.10.1 PROMINENT COMPANIES
5.10.2 SMALL & MEDIUM-SIZED COMPANIES
5.10.3 END USERS
FIGURE 19 SUPPLY CHAIN ANALYSIS OF ROBOTIC RADIOTHERAPY MARKET
5.11 PRICING ANALYSIS
TABLE 13 PRICING ANALYSIS OF RADIOTHERAPY SYSTEMS (USD)
5.12 PATENT ANALYSIS
FIGURE 20 TOP TEN PATENT APPLICANTS FOR RADIOTHERAPY (JANUARY 2012 TO JUNE 2022)
FIGURE 21 TOP TEN PATENT INVENTORS FOR RADIOTHERAPY (JANUARY 2012 TO JUNE 2023)
FIGURE 22 TOP TEN PATENT OWNERS FOR RADIOTHERAPY (JANUARY 2012 TO JUNE 2023)
5.13 TRADE ANALYSIS
TABLE 14 IMPORT DATA FOR RADIOTHERAPY SYSTEMS (HS CODE 9022), BY COUNTRY, 2018–2022 (USD THOUSAND)
TABLE 15 EXPORT DATA FOR RADIOTHERAPY SYSTEMS (HS CODE 9022), BY COUNTRY, 2018–2022 (USD THOUSAND)
5.14 KEY CONFERENCES AND EVENTS IN 2022–2023
TABLE 16 ROBOTIC RADIOTHERAPY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2022–2023
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 23 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
6 ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 17 ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
6.2 RADIOTHERAPY SYSTEMS
6.2.1 RISING USE OF AI AND AUTOMATION TO DRIVE MARKET
TABLE 18 RADIOTHERAPY SYSTEMS MARKET, BY REGION, 2020–2028 (USD MILLION)
6.3 SOFTWARE
6.3.1 NEED TO ENSURE TREATMENT EFFECTIVENESS AND ACCURACY TO BOOST GROWTH
TABLE 19 SOFTWARE MARKET, BY REGION, 2020–2028 (USD MILLION)
6.4 3D CAMERAS
6.4.1 GROWING USE OF SGRT TO DRIVE DEMAND
TABLE 20 3D CAMERAS MARKET, BY REGION, 2020–2028 (USD MILLION)
6.5 OTHER PRODUCTS
TABLE 21 OTHER ROBOTIC RADIOTHERAPY MARKET, BY REGION, 2020–2028 (USD MILLION)
7 ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 22 ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)
7.2 LINEAR ACCELERATORS
TABLE 23 LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2028 (USD MILLION)
7.2.1 CONVENTIONAL LINEAR ACCELERATORS
7.2.1.1 Longer treatment duration to limit adoption
7.2.2 MRI LINEAR ACCELERATORS
7.2.2.1 Rising awareness about benefits to enhance demand
7.3 STEREOTACTIC RADIATION THERAPY
TABLE 24 STEREOTACTIC RADIATION THERAPY MARKET, BY TYPE, 2020–2028 (USD MILLION)
7.3.1 CYBERKNIFE
7.3.1.1 Precision and correction capabilities to boost adoption
7.3.2 GAMMA KNIFE
7.3.2.1 Ongoing product development to drive market
7.4 PARTICLE THERAPY SYSTEMS
TABLE 25 PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION)
7.4.1 PROTON BEAM THERAPY
7.4.1.1 Rising establishment of proton therapy cancer centers to drive market
7.4.2 HEAVY ION THERAPY
7.4.2.1 Limited number of facilities to slow growth
8 ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 26 ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
8.2 LUNG CANCER
8.2.1 LUNG CANCER TO DOMINATE APPLICATIONS MARKET
TABLE 27 ROBOTIC RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2020–2028 (USD MILLION)
8.3 BREAST CANCER
8.3.1 INCREASING INCIDENCE OF BREAST CANCER TO DRIVE MARKET
TABLE 28 ROBOTIC RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2020–2028 (USD MILLION)
8.4 PROSTATE CANCER
8.4.1 PREFERENCE FOR NONINVASIVE TREATMENT TO BOOST GROWTH
TABLE 29 ROBOTIC RADIOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2020–2028 (USD MILLION)
8.5 HEAD & NECK CANCER
8.5.1 GROWING UTILIZATION OF CYBERKNIFE FOR TREATMENT TO DRIVE MARKET
TABLE 30 ROBOTIC RADIOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2020–2028 (USD MILLION)
8.6 COLORECTAL CANCER
8.6.1 RISING INCIDENCE OF COLORECTAL CANCER TO SUPPORT GROWTH
TABLE 31 ROBOTIC RADIOTHERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2020–2028 (USD MILLION)
8.7 OTHER CANCERS
TABLE 32 ROBOTIC RADIOTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2020–2028 (USD MILLION)
9 ROBOTIC RADIOTHERAPY MARKET, BY END USER
9.1 INTRODUCTION
TABLE 33 ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)
9.2 HOSPITALS
9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO PROPEL MARKET
TABLE 34 ROBOTIC RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2020–2028 (USD MILLION)
9.3 INDEPENDENT RADIOTHERAPY CENTERS
9.3.1 LIMITED SURGICAL CAPABILITIES OF AVAILABLE PRODUCTS TO RESTRAIN ADOPTION
TABLE 35 ROBOTIC RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2020–2028 (USD MILLION)
10 ROBOTIC RADIOTHERAPY MARKET, BY REGION
10.1 INTRODUCTION
TABLE 36 ROBOTIC RADIOTHERAPY MARKET, BY REGION, 2020–2028 (USD MILLION)
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 24 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET SNAPSHOT
TABLE 37 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY, 2020–2028 (USD MILLION)
TABLE 38 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)
TABLE 40 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
TABLE 41 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)
10.2.2 US
10.2.2.1 US to dominate North American market over forecast period
TABLE 42 US: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Increasing government initiatives and favorable reimbursement to drive market
TABLE 43 CANADA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
TABLE 44 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY, 2020–2028 (USD MILLION)
TABLE 45 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
TABLE 46 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)
TABLE 47 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
TABLE 48 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 Increasing aging population and rising life expectancy to drive market
TABLE 49 GERMANY: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Well-developed healthcare sector and rising geriatric population to drive market
TABLE 50 FRANCE: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.3.4 UK
10.3.4.1 High burden of chronic diseases to support adoption
TABLE 51 UK: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Increasing geriatric population to drive market
TABLE 52 ITALY: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Technological developments in healthcare to drive market
TABLE 53 SPAIN: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 54 REST OF EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 25 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET SNAPSHOT
TABLE 55 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY, 2020–2028 (USD MILLION)
TABLE 56 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
TABLE 57 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)
TABLE 58 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
TABLE 59 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising geriatric population and surgical procedures to drive market
TABLE 60 JAPAN: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.3 CHINA
10.4.3.1 Developing healthcare infrastructure to drive market
TABLE 61 CHINA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Rising awareness and government support to boost growth
TABLE 62 INDIA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Well-established healthcare system to favor adoption
TABLE 63 AUSTRALIA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.6 SOUTH KOREA
10.4.6.1 Growing target patient population to drive market
TABLE 64 SOUTH KOREA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC
TABLE 65 REST OF ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.5 REST OF THE WORLD
10.5.1 REST OF THE WORLD: RECESSION IMPACT
TABLE 66 REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
TABLE 67 REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)
TABLE 68 REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
TABLE 69 REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES
FIGURE 26 KEY DEVELOPMENTS IN ROBOTIC RADIOTHERAPY MARKET (2019 TO 2023)
11.3 REVENUE ANALYSIS
FIGURE 27 REVENUE ANALYSIS OF TOP FIVE PLAYERS (2019–2022)
11.4 MARKET SHARE ANALYSIS: ROBOTIC RADIOTHERAPY MARKET, BY KEY PLAYER (2022)
FIGURE 28 ROBOTIC RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 70 ROBOTIC RADIOTHERAPY MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX (2022)
11.5.1 STARS
11.5.2 PERVASIVE PLAYERS
11.5.3 EMERGING LEADERS
11.5.4 PARTICIPANTS
FIGURE 29 ROBOTIC RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX, 2022
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 DYNAMIC COMPANIES
11.6.3 RESPONSIVE COMPANIES
11.6.4 STARTING BLOCKS
FIGURE 30 COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
11.7 COMPETITIVE BENCHMARKING
11.7.1 OVERALL COMPANY FOOTPRINT
TABLE 71 OVERALL FOOTPRINT ANALYSIS: ROBOTIC RADIOTHERAPY MARKET
11.7.2 COMPANY PRODUCT FOOTPRINT
TABLE 72 PRODUCT FOOTPRINT ANALYSIS: ROBOTIC RADIOTHERAPY MARKET
11.7.3 COMPANY REGIONAL FOOTPRINT
TABLE 73 REGIONAL FOOTPRINT ANALYSIS: ROBOTIC RADIOTHERAPY MARKET
11.8 COMPETITIVE SCENARIO (2019–2023)
11.8.1 PRODUCT LAUNCHES & APPROVALS
11.8.2 DEALS
11.8.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, Recent Developments, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats)*
12.1.1 SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.)
TABLE 74 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
FIGURE 31 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2022)
12.1.2 ELEKTA
TABLE 75 ELEKTA: COMPANY OVERVIEW
FIGURE 32 ELEKTA: COMPANY SNAPSHOT (2022)
12.1.3 ACCURAY INCORPORATED
TABLE 76 ACCURAY INCORPORATED: COMPANY OVERVIEW
FIGURE 33 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2022)
12.1.4 VIEWRAY TECHNOLOGIES, INC.
TABLE 77 VIEWRAY TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 34 VIEWRAY TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
12.1.5 C-RAD
TABLE 78 C-RAD: COMPANY OVERVIEW
FIGURE 35 C-RAD: COMPANY SNAPSHOT (2022)
12.1.6 IBA
TABLE 79 IBA: COMPANY OVERVIEW
FIGURE 36 IBA: COMPANY SNAPSHOT (2022)
12.1.7 HITACHI LTD.
TABLE 80 HITACHI LTD.: COMPANY OVERVIEW
FIGURE 37 HITACHI LTD.: COMPANY SNAPSHOT (2021)
12.1.8 MEVION MEDICAL SYSTEMS
TABLE 81 MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW
12.1.9 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
TABLE 82 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: COMPANY OVERVIEW
12.1.10 P-CURE
TABLE 83 P-CURE: COMPANY OVERVIEW
12.1.11 PROVISION HEALTHCARE
TABLE 84 PROVISION HEALTHCARE: COMPANY OVERVIEW
12.1.12 SUMITOMO HEAVY INDUSTRY LTD.
TABLE 85 SUMITOMO HEAVY INDUSTRY LTD.: COMPANY OVERVIEW
FIGURE 38 SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT (2021)
12.1.13 PHILIPS HEALTHCARE
TABLE 86 PHILIPS HEALTHCARE: COMPANY OVERVIEW
FIGURE 39 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022)
12.1.14 RAYSEARCH LABORATORIES
TABLE 87 RAYSEARCH LABORATORIES: COMPANY OVERVIEW
FIGURE 40 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2022)
12.1.15 PROTOM INTERNATIONAL, INC.
TABLE 88 PROTOM INTERNATIONAL, INC.: COMPANY OVERVIEW
12.1.16 OPTIVUS PROTON THERAPY, INC.
TABLE 89 OPTIVUS PROTON THERAPY, INC.: COMPANY OVERVIEW
12.1.17 TOSHIBA CORPORATION
TABLE 90 TOSHIBA CORPORATION: COMPANY OVERVIEW
FIGURE 41 TOSHIBA CORPORATION: COMPANY SNAPSHOT (2022)
12.1.18 VISION RT LTD.
TABLE 91 VISION RT LTD.: COMPANY OVERVIEW
12.1.19 ADVANCED ONCOTHERAPY PLC
TABLE 92 ADVANCED ONCOTHERAPY PLC: COMPANY OVERVIEW
12.1.20 MIM SOFTWARE INC.
TABLE 93 MIM SOFTWARE INC.: COMPANY OVERVIEW
*Business Overview, Products/Services/Solutions Offered, Recent Developments, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 STANDARD IMAGING, INC.
12.2.2 BRAINLAB AG
12.2.3 MAGNETTX ONCOLOGY SOLUTIONS LTD.
12.2.4 PTW FREIBURG GMBH
12.2.5 DOSISOFT SA
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
